CD34 and acquired polycythemia vera: CD34+ hematopoietic stem and progenitor cells from JAK2V617F+ primary myelofibrosis exhibited a greater number of dysregulated genes than those from JAK2V617F+ polycythemia vera and JAK2V617F+ essential thrombocythemia